XETRA - Delayed Quote EUR
Maternus-Kliniken Aktiengesellschaft (MAK.DE)
1.5800
0.0000
(0.00%)
As of May 13 at 5:36:18 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
102,306
102,306
106,697
111,437
114,299
Cost of Revenue
14,860
14,860
19,718
13,921
16,600
Gross Profit
87,446
87,446
86,979
97,516
97,699
Operating Expense
96,707
96,707
97,123
96,405
96,150
Operating Income
-9,261
-9,261
-10,144
1,111
1,549
Net Non Operating Interest Income Expense
-7,398
-7,398
-5,727
-5,930
-7,160
Pretax Income
-12,583
-12,583
-12,826
-2,040
-7,777
Tax Provision
1,674
1,674
1,251
521
1,845
Net Income Common Stockholders
-14,257
-14,257
-14,077
-2,561
-9,623
Diluted NI Available to Com Stockholders
-14,257
-14,257
-14,077
-2,561
-9,623
Basic EPS
-0.68
-0.68
-0.67
-0.12
-0.46
Diluted EPS
-0.68
-0.68
-0.67
-0.12
-0.46
Basic Average Shares
20,970
20,970
20,970
20,970
20,970
Diluted Average Shares
20,970
20,970
20,970
20,970
20,970
Rent Expense Supplemental
176
176
245
287
403
Total Expenses
111,567
111,567
116,841
110,326
112,750
Net Income from Continuing & Discontinued Operation
-14,257
-14,257
-14,077
-2,561
-9,623
Normalized Income
-17,628.9500
-17,628.9500
-14,751.0500
-4,416.7000
-9,623
Interest Income
155
155
49
80
76
Interest Expense
7,553
7,553
5,776
6,010
7,236
Net Interest Income
-7,398
-7,398
-5,727
-5,930
-7,160
EBIT
-5,030
-5,030
-7,050
3,970
-541
EBITDA
4,715
4,715
3,965
15,087
11,044
Reconciled Cost of Revenue
14,860
14,860
19,718
13,921
16,600
Reconciled Depreciation
9,745
9,745
11,015
11,117
11,585
Net Income from Continuing Operation Net Minority Interest
-14,257
-14,257
-14,077
-2,561
-9,623
Total Unusual Items Excluding Goodwill
3,967
3,967
793
2,651
--
Total Unusual Items
3,967
3,967
793
2,651
--
Normalized EBITDA
748
748
3,172
12,436
11,044
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
595.0500
595.0500
118.9500
795.3000
0
12/31/2020 - 5/21/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade